Trial reportBritish journal of haematology2020
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
Abstract readClinical TrialLetterMulticenter Study
In one paragraph
Trial report in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports.Annals of hematology · 2024Pooled it
- The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.Journal of autoimmunity · 2021Pooled it
- Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.Frontiers in immunologyPooled it
- The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus.Nature reviews. Endocrinology · 2024Review
- The laboratory parameters in predicting the severity and death of COVID-19 patients: Future pandemic readiness strategies.Biomolecules & biomedicine · 2024Review
- COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches.Cell communication and signaling : CCS · 2024Review
- Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study.Open medicine (Warsaw, Poland) · 2024Article
- Predictor Factors for Chronicity in Immune Thrombocytopenic Purpura in Children.Children (Basel, Switzerland) · 2023Article
- Article
- How we treat primary immune thrombocytopenia in adults.Journal of hematology & oncology · 2023Review
- Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.Pediatric blood & cancer · 2023Article
- Case mistaken for leukemia after mRNA COVID-19 vaccine administration: A case report.World journal of clinical cases · 2022Article
- Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.International immunopharmacology · 2022Review
- Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.Haematologica · 2022Article
- SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia.Pediatric blood & cancer · 2022Article
- Article
- Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience.EJHaem · 2022Article
- Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.Annals of hematology · 2022Review
- De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.Blood · 2022Article
- Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery.Journal of stomatology, oral and maxillofacial surgery · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Matthieu MahévasDepartment of Internal Medicine, National Referral Center for Adult's Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.ORCID 0000-0001-9913-7741
Guillaume MoulisDepartment of Internal Medicine, Toulouse University Hospital (CHU de Toulouse), Toulouse, France.
Emmanuel AndresDepartment of Internal Medicine, University Hospital of Strasbourg, Research Team EA, 3072 "Mitochondrie, Stress oxydant et Protection musculaire", University of Strasbourg, Strasbourg, France.
Etienne RiviereDepartment of Internal Medicine, Bordeaux University Hospital (CHU de Bordeaux), Bordeaux, France.
Margaux GarzaroDepartment of Clinical Immunology, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
Etienne CrickxDepartment of Internal Medicine, National Referral Center for Adult's Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.
Vivien GuillotinDepartment of Internal Medicine, University Hospital of Strasbourg, Research Team EA, 3072 "Mitochondrie, Stress oxydant et Protection musculaire", University of Strasbourg, Strasbourg, France.
Marion MalphettesDepartment of Clinical Immunology, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.ORCID 0000-0002-9888-2528
Lionel GalicierDepartment of Clinical Immunology, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.ORCID 0000-0002-0360-7620
Nicolas NoelDepartment of internal medicine, Kremlin-Bicêtre, Assistance Publique Hôpitaux de Paris, Paris, France.ORCID 0000-0003-4055-617X
Luc DarnigeInserm UMR-S 1140, Service d'Hématologie Biologique, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.ORCID 0000-0003-3210-2821
Louis TerriouDepartment of Internal Medicine and Immunology, Claude-Huriez University Hospital, Université Lille Nord de France, Lille, France.
Claire GuervenoDepartment of Internal Medicine, Albi Hospital, Albi, France.
Mateo Sanchis-BorjaDepartment of pneumology, Hôpital européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.
Thomas MoulinetDepartment of internal medicine, Nancy University Hospital (CHU de Nancy), University of Lorraine, Vandoeuvre-lès-Nancy, France.
Benoit MeunierDepartment of internal medicine, Hôpital la Timone, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.
Mikael EbboDepartment of internal medicine, Hôpital la Timone, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.
Marc MichelDepartment of Internal Medicine, National Referral Center for Adult's Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.
Bertrand GodeauDepartment of Internal Medicine, National Referral Center for Adult's Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Purpura, Thrombocytopenic, IdiopathicSARS-CoV-2AdultFemaleFranceHumansMaleMiddle AgedYoung AdultCOVID-19ITPTreatment
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.